NCT02834390 2025-03-05
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Daiichi Sankyo
Phase 1 Completed
Daiichi Sankyo
AbbVie
PharmaMar
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
Baylor College of Medicine
National Cancer Institute (NCI)